Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
Heart rhythm device gets Long-Term safety check
Disease control Recruiting nowThis study is checking the long-term safety and effectiveness of an FDA-approved catheter system for treating irregular heartbeats. It involves 276 people with symptomatic atrial fibrillation who haven't responded well to medication. The research focuses on whether the treatment …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Massive 8,000-Patient study tracks Real-World safety of heart procedure tools
Disease control Recruiting nowThis study is collecting real-world safety and performance data on already-approved medical devices used to treat irregular heartbeats. It will follow 8,000 patients who are scheduled to have a standard heart rhythm procedure. The goal is to confirm the devices work safely in eve…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New heart procedure trial aims to zap away irregular heartbeats
Disease control Recruiting nowThis study is testing a new pulsed field ablation system to treat people with symptomatic paroxysmal atrial fibrillation, a type of irregular heartbeat. The procedure aims to isolate problematic heart veins to prevent abnormal rhythms. Researchers will enroll 440 participants to …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
New catheter aims to pinpoint dangerous heart rhythms
Diagnosis Recruiting nowThis study is testing a new, paddle-shaped catheter designed to create detailed maps of irregular heartbeats. Doctors will use it on 60 patients with conditions like atrial fibrillation or ventricular tachycardia to see if it's safe and works well. The goal is to see if this tool…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC